A major limitation of present-day long-term drug therapy for Parkinsonism is:
A) a high incidence of serious liver toxicity associated with levodopa.
B) a rebound or withdrawal effect following discontinuation of treatment.
C) a sensitization phenomenon wherein less and less drug is needed even as dyskinesia and other
D) decreased responsiveness to levadopa.
Correct Answer:
Verified
Q1: Based on your knowledge of the cellular
Q3: The mainstay of pharmacological treatment for behavioral
Q4: At the cellular level,the biological basis for
Q5: The two main COMT-inhibitory drugs talcapone and
Q6: The mainstay of therapy for Parkinson's disease
Q7: MAO-A is associated with _; MAO-B is
Q8: Symptoms of Parkinson's disease are frequently a
Q9: The new dopamine receptor agonists are _
Q11: The precursor of levadopa is:
A)dopamine.
B)dopa decarboxylase.
C)tyramine.
D)tyrosine.
Q15: The clinical syndrome of Parkinsonism includes all
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents